http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Baxter Announces Exclusive Distribution Agreement With bioMérieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.
-
Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors
-
Baxter (BAX) Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy
-
Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy
-
Baxter to Present at the Virtual Morgan Stanley 18th Annual Global Healthcare Conference
-
Baxter to Present at the 2020 Wells Fargo Virtual Healthcare Conference
-
Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT
-
Baxter (BAX) Obtains U.S. FDA EUA for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic
-
Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic
-
Baxter Introduces Virtual Peritoneal Dialysis Excellence Academy for Nurses in the U.S.
-
Baxter Reports Second-Quarter 2020 Results
-
Baxter and Ayogo Announce Partnership for Unique Digital Health Solutions for Home Dialysis
-
Baxter (BAX), VIPUN Medical Announce Collaboration to Commercialize Innovative Gastric Monitoring System to Help Enhance Clinical Nutrition
-
Baxter and VIPUN Medical Announce Collaboration to Commercialize Innovative Gastric Monitoring System to Help Enhance Clinical Nutrition
-
Baxter Ranks in Top 10% on 2020 Disability Equality Index
-
Baxter Declares Quarterly Dividend
-
Baxter to Host Second-Quarter 2020 Financial Results Conference Call for Investors
-
Baxter (BAX) Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery
-
Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen
-
Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During the 57th ERA-EDTA Virtual Congress
-
Baxter to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast
-
Baxter (BAX) Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System
-
Baxter Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform
-
Baxter Announces Results of Clinical Trial on Benefits of Dynamic Fluid Management in Septic Shock Patients
-
Baxter Increases Dividend and Declares Quarterly Dividend
-
Baxter Reports First-Quarter 2020 Results
-
Baxter to Present at the UBS Virtual Global Healthcare Conference
-
Baxter to Present at the Virtual BofA Securities 2020 Health Care Conference
-
Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment
-
Baxter to Host First-Quarter 2020 Financial Results Conference Call for Investors
-
Baxter (BAX) Provides Update on COVID-19 Response Efforts
-
Baxter Provides Update on COVID-19 Response Efforts
-
Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format
-
Baxter Reports Fourth-Quarter and Full-Year 2019 Results, Completes Financial Restatement Process
-
Baxter to Host Fourth-quarter 2019 Financial Results Conference Call for Investors
-
Baxter Launches Peri-Strips Dry With Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical Procedures
-
Baxter to Present at the Raymond James 41st Annual Institutional Investors Conference
-
Baxter Declares Quarterly Dividend
-
Baxter Completes Acquisition of Seprafilm Adhesion Barrier
-
Baxter (BAX), COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ Indirect Calorimetry Device
-
Baxter and COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ Indirect Calorimetry Device
-
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
-
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
-
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
-
Baxter to Present at the 9th Annual SVB Leerink Global Healthcare Conference
-
Baxter (BAX) Reports Prelim. Q4 & FY19 Sales Above Consensus; Provides FY20 Guidance
-
Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance
-
Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference
-
Baxter (BAX) to acquire Seprafilm Adhesion Barrier from Sanofi (SNY) for $350 Million
-
Baxter to Expand Advanced Surgery Portfolio With Acquisition of Seprafilm Adhesion Barrier

